ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2020

Investigation of the Effect of Canagliflozin on the Disposition Index, a Marker of Pancreatic Beta Cell Function, in Patients with Type 2 Diabetes.

Mitsuyoshi Takahara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.